Hoffmann JH, Knoop C, Enk AH, Hadaschik EN. Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-term Treatment with Adalimumab, Etanercept, and Ustekinumab. Acta Derm Venereol [Internet]. 2017 Mar. 16 [cited 2026 Jun. 22];97(6):705-10. Available from: https://medicaljournalssweden.se/actadv/article/view/5128